Inhibition of ataxia telangiectasia related-3 (ATR) improves therapeutic index in preclinical models of non-small cell lung cancer (NSCLC) radiotherapy

Research output: Contribution to journalArticle

11 Citations (Scopus)
257 Downloads (Pure)

Fingerprint Dive into the research topics of 'Inhibition of ataxia telangiectasia related-3 (ATR) improves therapeutic index in preclinical models of non-small cell lung cancer (NSCLC) radiotherapy'. Together they form a unique fingerprint.

Medicine & Life Sciences